Cargando…

Epigenetic and transcriptome responsiveness to ER modulation by tissue selective estrogen complexes in breast epithelial and breast cancer cells

Selective estrogen receptor modulators (SERMs), including the SERM/SERD bazedoxifene (BZA), are used to treat postmenopausal osteoporosis and may reduce breast cancer (BCa) risk. One of the most persistent unresolved questions regarding menopausal hormone therapy is compromised control of proliferat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Messier, Terri L., Boyd, Joseph R., Gordon, Jonathan A. R., Tye, Coralee E., Page, Natalie A., Toor, Rabail H., Zaidi, Sayyed K., Komm, Barry S., Frietze, Seth, Stein, Janet L., Lian, Jane B., Stein, Gary S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9302754/ https://www.ncbi.nlm.nih.gov/pubmed/35862394 http://dx.doi.org/10.1371/journal.pone.0271725

Ejemplares similares

Oncogenic epigenetic control
por: Stein, Gary S., et al.
Publicado: (2016)

Histone H3 lysine 4 acetylation and methylation dynamics define breast cancer subtypes
por: Messier, Terri L., et al.
Publicado: (2016)

Disruption of Broad Epigenetic Domains in PDAC Cells by HAT Inhibitors
por: Gerrard, Diana L., et al.
Publicado: (2019)

Chromatin interaction analysis reveals changes in small chromosome and telomere clustering between epithelial and breast cancer cells
por: Barutcu, A. Rasim, et al.
Publicado: (2015)

Runx1 stabilizes the mammary epithelial cell phenotype and prevents epithelial to mesenchymal transition
por: Hong, Deli, et al.
Publicado: (2017)

LncMIR181A1HG is a novel chromatin-bound epigenetic suppressor of early stage osteogenic lineage commitment
por: Tye, Coralee E., et al.
Publicado: (2022)

Breast-related effects of selective estrogen receptor modulators and tissue-selective estrogen complexes
por: Smith, Carolyn L, et al.
Publicado: (2014)

Targeting estrogen to kill ER-positive and ER-negative breast cancer
por: Jordan, VC
Publicado: (2005)

Epigenetic reactivation of estrogen receptor-α (ERα) by genistein enhances hormonal therapy sensitivity in ERα-negative breast cancer
por: Li, Yuanyuan, et al.
Publicado: (2013)

Estrogen Signaling in ERα-Negative Breast Cancer: ERβ and GPER
por: Girgert, Rainer, et al.
Publicado: (2019)

Epigenetic regulation of estrogen signaling in breast cancer
por: Hervouet, Eric, et al.
Publicado: (2013)

peaksat: an R package for ChIP-seq peak saturation analysis
por: Boyd, Joseph R, et al.
Publicado: (2023)

Estrogen receptor variants in ER-positive basal-type breast cancers responding to therapy like ER-negative breast cancers
por: Groenendijk, Floris H., et al.
Publicado: (2019)

Apigenin, a Partial Antagonist of the Estrogen Receptor (ER), Inhibits ER-Positive Breast Cancer Cell Proliferation through Akt/FOXM1 Signaling
por: Pham, Thu Ha, et al.
Publicado: (2021)

Estrogens Correlate with PELP1 Expression in ER Positive Breast Cancer
por: Flågeng, Marianne Hauglid, et al.
Publicado: (2015)

Endogenous and Therapeutic Estrogens: Maestro Conductors of the Microenvironment of ER+ Breast Cancers
por: Schuler, Linda A., et al.
Publicado: (2021)

ERβ as a mediator of estrogen signaling in inflammatory breast cancer
por: Nagandla, Harika, et al.
Publicado: (2023)

Synergistic epigenetic reactivation of estrogen receptor-α (ERα) by combined green tea polyphenol and histone deacetylase inhibitor in ERα-negative breast cancer cells
por: Li, Yuanyuan, et al.
Publicado: (2010)

A Novel Combinatorial Epigenetic Therapy Using Resveratrol and Pterostilbene for Restoring Estrogen Receptor-α (ERα) Expression in ERα-Negative Breast Cancer Cells
por: Kala, Rishabh, et al.
Publicado: (2016)

Estrogen receptor inhibition mediates radiosensitization of ER-positive breast cancer models
por: Michmerhuizen, Anna R., et al.
Publicado: (2022)

Estrogen receptor (ER) was regulated by RNPC1 stabilizing mRNA in ER positive breast cancer
por: Shi, Liang, et al.
Publicado: (2015)

Autocrine IGF-I/insulin receptor axis compensates for inhibition of AKT in ER-positive breast cancer cells with resistance to estrogen deprivation
por: Fox, Emily M, et al.
Publicado: (2013)

Estrogen therapy induces an unfolded protein response to drive cell death in ER+ breast cancer
por: Hosford, Sarah R., et al.
Publicado: (2019)

LINC01638 Sustains Human Mesenchymal Stem Cell Self-Renewal and Competency for Osteogenic Cell Fate
por: Gordon, Jonathan, et al.
Publicado: (2023)

Spatiotemporal control of estrogen-responsive transcription in ERα-positive breast cancer cells
por: Hsu, P-Y, et al.
Publicado: (2016)

LINC01638 sustains human mesenchymal stem cell self-renewal and competency for osteogenic cell fate
por: Gordon, Jonathan A. R., et al.
Publicado: (2023)

Regulation of ERα Stability and Estrogen Signaling in Breast Cancer by HOIL-1
por: Ding, Jianing, et al.
Publicado: (2021)

Clinical implication of low estrogen receptor (ER-low) expression in breast cancer
por: Reinert, Tomás, et al.
Publicado: (2022)

The Possible Impact of Obesity on Androgen, Progesterone and Estrogen Receptors (ERα and ERβ) Gene Expression in Breast Cancer Patients
por: Esfahlan, R. Jahanban, et al.
Publicado: (2011)

An estrogen receptor (ER)‐related signature in predicting prognosis of ER‐positive breast cancer following endocrine treatment
por: Tang, Jianing, et al.
Publicado: (2019)

Direct estrogen receptor (ER) / HER family crosstalk mediating sensitivity to lumretuzumab and pertuzumab in ER+ breast cancer
por: Collins, Denis, et al.
Publicado: (2017)

Dual effects of TGF-β on ERα-mediated estrogenic transcriptional activity in breast cancer
por: Ren, Yongsheng, et al.
Publicado: (2009)

Estrogen regulates divergent transcriptional and epigenetic cell states in breast cancer
por: Ors, Aysegul, et al.
Publicado: (2022)

Estrogen receptors and breast cancer.
por: Nicholson, R I, et al.
Publicado: (1981)

The selective estrogen receptor downregulator GDC-0810 is efficacious in diverse models of ER+ breast cancer
por: Joseph, James D, et al.
Publicado: (2016)

Resistance to everolimus driven by epigenetic regulation of MYC in ER+ breast cancers
por: Bihani, Teeru, et al.
Publicado: (2014)

Corrigendum to “Spatiotemporal higher-order chromatin landscape of human histone gene clusters at histone locus bodies during the cell cycle in breast cancer progression” [Gene 872 (2023) 147441]
por: Ghule, Prachi N., et al.
Publicado: (2023)

EPRS is a critical regulator of cell proliferation and estrogen signaling in ER(+) breast cancer
por: Katsyv, Igor, et al.
Publicado: (2016)

Dynamic interactions between the extracellular matrix and estrogen activity in progression of ER+ breast cancer
por: Jallow, Fatou, et al.
Publicado: (2019)

Lasofoxifene as a potential treatment for therapy-resistant ER-positive metastatic breast cancer
por: Lainé, Muriel, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vu4avddbtnsa8ab4vu5dg3utg8